These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 946146)
1. Effect of alpha-MSH on plasma levels of LH, FSH, progesterone and cortisol during the corpus luteum phase of the menstrual cycle. Runnebaum B; Heep J; Geiger W; Vecsei P; Andor J Acta Endocrinol (Copenh); 1976 Feb; 81(2):243-51. PubMed ID: 946146 [TBL] [Abstract][Full Text] [Related]
2. Effect of alpha-MSH on plasma LH, progesterone and cortisol during the luteal phase of the menstrual cycle. Runnebaum B; Heep J; Geiger W; Andor I Acta Endocrinol Suppl (Copenh); 1973; 173():41. PubMed ID: 4542120 [No Abstract] [Full Text] [Related]
3. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle. Grimes EM; Thompson IE; Taymor ML Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349 [TBL] [Abstract][Full Text] [Related]
4. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle. Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438 [TBL] [Abstract][Full Text] [Related]
5. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation. Croxatto HB; Salvatierra AM; Romero C; Spitz IM J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656 [TBL] [Abstract][Full Text] [Related]
6. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch. de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989 [TBL] [Abstract][Full Text] [Related]
7. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women. Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355 [TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. Filicori M; Butler JP; Crowley WF J Clin Invest; 1984 Jun; 73(6):1638-47. PubMed ID: 6427277 [TBL] [Abstract][Full Text] [Related]
9. Peripheral and not central suppression of ovarian function during osmotic pump infusion of adrenocorticotropin-(1-24) for one menstrual cycle in the cynomolgus monkey and its partial compensation by a transitory elevation of sex hormone-binding globulin levels. Kowalski W; Chatterton RT Endocrinology; 1992 Jun; 130(6):3582-92. PubMed ID: 1597155 [TBL] [Abstract][Full Text] [Related]
10. [LH, FSH and progesterone level in the blood plasma of women with normal menstrual cycle]. Pakhomova IA; Smilshkalne IIu; Ebela AK; Osha AV; Feodorova EP Probl Endokrinol (Mosk); 1976; 22(5):38-41. PubMed ID: 1023181 [TBL] [Abstract][Full Text] [Related]
11. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment. Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073 [TBL] [Abstract][Full Text] [Related]
12. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle. Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788 [TBL] [Abstract][Full Text] [Related]
13. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Reyes FI; Winter JS; Faiman C Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845 [TBL] [Abstract][Full Text] [Related]
14. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women. Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322 [TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH. Faure N; Olivier GC Horm Res; 1978; 9(1):12-21. PubMed ID: 338460 [TBL] [Abstract][Full Text] [Related]
16. LHRH and steroid levels in normal ovulatory women. Stone SC; Dickey RP; Kastin AJ; Schally AV Obstet Gynecol; 1976 Aug; 48(2):146-9. PubMed ID: 781572 [TBL] [Abstract][Full Text] [Related]
17. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state. de Kretser DM; Burger HG; Dumpys R J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423 [TBL] [Abstract][Full Text] [Related]
18. Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women. Lemay A; Labrie F; Raynaud JP Int J Fertil; 1980; 25(3):203-12. PubMed ID: 6108931 [TBL] [Abstract][Full Text] [Related]
19. Alpha-melanocyte-stimulating hormone antagonizes the inhibitory effect of corticotropin-releasing hormone on luteinizing hormone secretion during the luteal phase in normal women. Limone P; Scipioni T; Calvelli P; Scaglione E; Barberis AM; Dentelli P; Isaia GC; Molinatti GM J Clin Endocrinol Metab; 1994 Aug; 79(2):571-5. PubMed ID: 8045978 [TBL] [Abstract][Full Text] [Related]
20. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment]. Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]